// Definition
The pharmacological action of CBD on serotonin 5-HT1A receptors, which contributes to its anxiolytic and anti-depressant effects independent of the endocannabinoid system.
// From the Episode
Discussed in ep080 referencing a neuropharmacology report. The panel noted CBD's activity at serotonin 5-HT1A receptors as a mechanism separate from its cannabinoid interactions, explaining rapid onset anti-anxiety effects. This dual mechanism helps explain why CBD can be effective for conditions beyond traditional cannabinoid-responsive disorders.
// Source
Ep. 080 Hash Church LXXX 80 →